| 國立臺灣大學 |
2014 |
Hepatitis B virus reactivation after ustekinumab treatment: reply from authors
|
Tsai, T. -F.; 蔡呈芳 |
| 臺大學術典藏 |
2022-08-19T00:20:52Z |
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
|
Kim W.S.; Kwong Y.-L.; Suh C.; Lim S.T.; Cheng A.-L.; Chng W.-J.; Lee J.; Intragumtornchai T.; Kim S.J.; CHIUN HSU; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
|
Cheng A.-L.; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S.; Chng W.-J.; Kim S.J.; Chiun Hsu; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
|
Kim S.J.; Hsu C.; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S. |
| 國立臺灣大學 |
2013 |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
|
Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; Chen, Pei-Jer; PEI-JER CHEN; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-09-04T06:11:52Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:49Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu, C.-H. and Liu, C.-J. and Su, T.-H. and Fang, Y.-J. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-03-09T01:43:25Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:30Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
CHEN-HUA LIU; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:43Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:24Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; CHUN-JEN LIU; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:10:55Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-07-12T02:44:36Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H; | Liu C.-J; | Su T.-H; | Fang Y.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 國立臺灣大學 |
2007 |
Hepatitis B Virus Seropositivity Is Not Associated with Increased Risk of Carotid Atherosclerosis in Taiwanese
|
楊鎧鍵; 陳明豐; 蘇大成; 鄭建興; 林亮宇; 廖朝崧; 李源德; YANG, KAI-CHIEN; CHEN, MING-FONG; SU, TA- CHEN; JENG, JIANN-SHING; LIN, LIAN-YU; LIAU, CHIAU-SUONG; LEE, YUAN-THE |
| 國立臺灣大學 |
2007-12 |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
Yang, KC; Chen, MF; Su, TC; Jeng, JS; Hwang, BS; Lin, LY; Liau, CS; Lee, YT. |
| 中國醫藥大學 |
2007-12 |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
(Yang KC); (Chen MF); (Su TC); (Jeng JS); (Hwang BS); (Lin LY); (Liau CS); 李源德(Yuan-Teh, Lee) |
| 臺大學術典藏 |
2007 |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
Yang K.-C.; Chen M.-F.; Su T.-C.; JIANN-SHING JENG; Hwang B.-S.; Lin L.-Y.; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
2020-09-28T02:47:56Z |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
Lee Y.-T.; Liau C.-S.; Yang K.-C.;Chen M.-F.;Ta-Chen Su;Jeng J.-S.;Hwang B.-S.;Lin L.-Y.;Liau C.-S.;Lee Y.-T.; Yang K.-C.; Chen M.-F.; TA-CHEN SU; Jeng J.-S.; Hwang B.-S.; Lin L.-Y. |
| 臺大學術典藏 |
2020-11-03T11:45:10Z |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
Lee Y.-T.; Liau C.-S.; Lin L.-Y.; Hwang B.-S.; JIANN-SHING JENG; Su T.-C.; Chen M.-F.; Yang K.-C.; Yang K.-C.;Chen M.-F.;Su T.-C.;Jiann-Shing Jeng;Hwang B.-S.;Lin L.-Y.;Liau C.-S.;Lee Y.-T. |
| 臺大學術典藏 |
2021-05-07T06:48:05Z |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
KAI-CHIEN YANG; Chen M.-F.; Su T.-C.; Jeng J.-S.; Hwang B.-S.; Lin L.-Y.; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
2020-12-04T07:45:21Z |
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
|
Yang K.-C.; Chen M.-F.; Su T.-C.; Jeng J.-S.; Hwang B.-S.; LIAN-YU LIN; Liau C.-S.; Lee Y.-T. |
